{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:12330"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:12330","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Biomarkers predict outcomes in patients with atrial fibrillation and cardiovascular conditions","abstract":"Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia with a prevalence of 3-4%. Thirteen cardiovascular biomarkers selected in a Delphi process were centrally quantified on high-precision, high-throughput analysers (Roche Diagnostics, Penzberg, Germany) in 1620 patients recruited into Birmingham Black Country Atrial Fibrillation Registry at Sandwell and West Birmingham NHS Trust. Follow-up information on outcomes (cardiovascular death, heart failure hospitalization, stroke or systemic embolism and acute coronary syndrome) were obtained using health records and central mortality data from NHS digital. Follow-up was for a median of 4.2 (IQR 3.5–4.9) years with analysis performed at 2.5 years. Clinical characteristics and biomarker concentrations were related to outcomes. Study 1 examines the value of NT-proBNP in predicting cardiovascular death or heart failure hospitalization in phenotype groups based on AF and heart failure status. Study 2 examines biomarker predictors and clinical predictors of major adverse cardiovascular events (MACE) in patients with cardiovascular conditions.","abstract_html":"Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia with a prevalence of 3-4%. Thirteen cardiovascular biomarkers selected in a Delphi process were centrally quantified on high-precision, high-throughput analysers (Roche Diagnostics, Penzberg, Germany) in 1620 patients recruited into Birmingham Black Country Atrial Fibrillation Registry at Sandwell and West Birmingham NHS Trust. Follow-up information on outcomes (cardiovascular death, heart failure hospitalization, stroke or systemic embolism and acute coronary syndrome) were obtained using health records and central mortality data from NHS digital. Follow-up was for a median of 4.2 (IQR 3.5–4.9) years with analysis performed at 2.5 years. Clinical characteristics and biomarker concentrations were related to outcomes. Study 1 examines the value of NT-proBNP in predicting cardiovascular death or heart failure hospitalization in phenotype groups based on AF and heart failure status. Study 2 examines biomarker predictors and clinical predictors of major adverse cardiovascular events (MACE) in patients with cardiovascular conditions.","abstract_has_math":false,"creators":["Brady, Paul"],"institution":"University of Birmingham","degree_name":"h_md","degree_level":"h_md","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2022,"date_issued":"2022-07","date_published":"2022-07","updated_at":"2026-11-19T09:31:41Z","subjects":["RB Pathology","RC Internal medicine"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/12330/7/Brady2022MD_Redacted.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A12330","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["british_heart_foundation"]},{"key":"dc:creator","label":"Author","values":["Brady, Paul"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2022-07-14"]},{"key":"dc:date.issued","label":"Date","values":["2022-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Cardiovascular Sciences"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/12330/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["h_md"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["h_md"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["RB Pathology","RC Internal medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/12330/7/Brady2022MD_Redacted.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia with a prevalence of 3-4%. Thirteen cardiovascular biomarkers selected in a Delphi process were centrally quantified on high-precision, high-throughput analysers (Roche Diagnostics, Penzberg, Germany) in 1620 patients recruited into Birmingham Black Country Atrial Fibrillation Registry at Sandwell and West Birmingham NHS Trust. Follow-up information on outcomes (cardiovascular death, heart failure hospitalization, stroke or systemic embolism and acute coronary syndrome) were obtained using health records and central mortality data from NHS digital. Follow-up was for a median of 4.2 (IQR 3.5–4.9) years with analysis performed at 2.5 years. Clinical characteristics and biomarker concentrations were related to outcomes. Study 1 examines the value of NT-proBNP in predicting cardiovascular death or heart failure hospitalization in phenotype groups based on AF and heart failure status. Study 2 examines biomarker predictors and clinical predictors of major adverse cardiovascular events (MACE) in patients with cardiovascular conditions."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Biomarkers predict outcomes in patients with atrial fibrillation and cardiovascular conditions"]}]}],"canonical_facts":{"dc:contributor.sponsor":["british_heart_foundation"],"dc:creator":["Brady, Paul"],"dc:date":["2022-07-14"],"dc:date.issued":["2022-07"],"dc:description.abstract":["Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia with a prevalence of 3-4%. Thirteen cardiovascular biomarkers selected in a Delphi process were centrally quantified on high-precision, high-throughput analysers (Roche Diagnostics, Penzberg, Germany) in 1620 patients recruited into Birmingham Black Country Atrial Fibrillation Registry at Sandwell and West Birmingham NHS Trust. Follow-up information on outcomes (cardiovascular death, heart failure hospitalization, stroke or systemic embolism and acute coronary syndrome) were obtained using health records and central mortality data from NHS digital. Follow-up was for a median of 4.2 (IQR 3.5–4.9) years with analysis performed at 2.5 years. Clinical characteristics and biomarker concentrations were related to outcomes. Study 1 examines the value of NT-proBNP in predicting cardiovascular death or heart failure hospitalization in phenotype groups based on AF and heart failure status. Study 2 examines biomarker predictors and clinical predictors of major adverse cardiovascular events (MACE) in patients with cardiovascular conditions."],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/12330/7/Brady2022MD_Redacted.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Cardiovascular Sciences"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/12330/"],"dc:subject":["RB Pathology","RC Internal medicine"],"dcterms:accessrights":["public"],"dc:title":["Biomarkers predict outcomes in patients with atrial fibrillation and cardiovascular conditions"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["h_md"],"dc:type.qualificationname":["h_md"]},"updated_at":"2026-11-19T09:31:41Z"}